Evaluating HIV treatment as prevention in the European context
This report, commissioned by ECDC and produced by the Research Department of Infection and Population Health, University College London, gathers evidence regarding population-level, and to some extent, individual-level effects of the use of antiretroviral treatment to prevent HIV infection, and relating it to current HIV treatment guidelines. The report concludes that antiretroviral treatment has well documented benefits in reducing transmission of HIV, and has had major population level impact on HIV acquisition in children from HIV positive mothers. However it goes on to state that this policy cannot be used for all people with diagnosed HIV without understanding whether there is a benefit for personal health.
Public health guidance on active case finding of communicable diseases in prison settings
23 May 2018 - This joint guidance from ECDC and the European Monitoring Centre for Drugs and Drug Addiction provides EU/EEA Member States with evidence-based scientific advice on active case finding options. These options can be applied to the planning and implementation of interventions that promote the early diagnosis of communicable diseases in prison settings.
Public health guidance on antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA – addressing the vulnerable populations
21 Mar 2017 - This publication aims to support the strengthening of antenatal screening programmes for HIV, hepatitis B, syphilis and rubella susceptibility in the general population and in groups identified as vulnerable to mother-to-child-transmission in the EU/EEA.